The chemoresistance map characterize the various underlying factors of prostate cancer associated chemo & radiation resistance, comprising docetaxel & paclitaxel resistance, radiation resistance, androgen receptor mediated signaling, neuroendocrine behavior and the role of transcription factors. This evidence concerns the gene AR and prostate cancer.